Sujit, leisurely scrolling through his phone, gets an alert that launches him into an animated rant. Shreyas, caught in the splash zone, finds out about the issue and tries to calm him down. Sujit: He ...
U.S. President Donald Trump’s plan to impose steep tariffs on generic medicines has unsettled Indian drugmakers and put the spotlight on their strategy in their biggest export market. The NSE Nifty ...
Despite Washington’s move to tighten policy on pharmaceutical trade with a fresh threat of 100 per cent tariffs on generic drug imports, analysts say China’s pharmaceutical rise is now tariff-proof, ...
BRUSSELS — The European Commission said Wednesday that it expects European generic medicines to be exempt from U.S. President Donald Trump’s latest tariffs, arguing that Washington committed to a zero ...
US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go into effect in ...
A stepped tariff schedule targets generics only, preserving existing treatment for patented and innovative drugs while signaling punitive intent for firms that do not invest in U.S. plant and ...
South Africa’s health regulator is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisk’s blockbuster diabetes and weight-loss medicines, it said on ...
The administration has repeatedly said it will impose steep pharmaceutical tariffs but has not followed through on them. By Rebecca Robbins President Trump said on Tuesday evening that he planned to ...
ANI Pharmaceuticals (ANIP) is a speculative Buy because you have to clearly understand what you are buying. You are not just buying a quarterly estimate beat, or a share repurchase or a one-time ...
Use Spring MVC MultipartFile, Java Path APIs and the browser fetch API to upload files asynchronously and save them safely on the server. Follow the essential steps to download Java 21, configure ...
Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results